Steinberg v. Seitz

517 F.2d 1359, 186 U.S.P.Q. (BNA) 209
CourtCourt of Customs and Patent Appeals
DecidedJune 26, 1975
DocketPatent Appeal No. 75-524
StatusPublished
Cited by16 cases

This text of 517 F.2d 1359 (Steinberg v. Seitz) is published on Counsel Stack Legal Research, covering Court of Customs and Patent Appeals primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Steinberg v. Seitz, 517 F.2d 1359, 186 U.S.P.Q. (BNA) 209 (ccpa 1975).

Opinion

BALDWIN, Judge.

Steinberg et al. (hereinafter Steinberg) appeal from that portion of the decision of the Board of Patent Interferences which awarded priority of count 3 to Seitz et al., the junior party.1 We affirm.

The Subject Matter

The count in issue reads:

3. Apparatus for use in determining the prothrombin time [clotting time] of a blood sample comprising: a container for holding the blood sample, a freely movable ferromagnetic member disposed in the container, a magnetic field source located near the container and forming a weak magnetic couple with the ferromagnetic member, means for producing relative movement between the ferromagnetic member and the container, the intensity of the magnetic field source being sufficient to prevent relative movement between the ferromagnetic member and the magnetic field source prior to clotting but insufficient to prevent relative movement between the ferromagnetic member and the magnetic field source on clotting due to an increase in the resistance to movement of the ferromagnetic member in the container imposed on the ferromagnetic member by the blood sample, and means for deriving a signal in response to relative movement between the ferromagnetic member and the magnetic field source, the signal signifying the end point in determining the prothrombin time.

The recited apparatus is used for determining the length of time required for a patient’s blood to clot. Such information is useful in the treatment of the disease of hemophilia and other congenital or acquired bleeding disorders.

The Record

Steinberg took no testimony, but relied upon his October 20, 1967, filing date. Seitz et al. took testimony and introduced evidence to prove prior actual reduction to practice. The testimony includes that of one of the co-inventors, Seitz, and Owen, a graduate electrical engineer, who constructed a clot timer on behalf of Seitz et al. During the pertinent period, Seitz et al. were employed by the Hyland Division of Travenol Laboratories, the latter being the operating subsidiary of Baxter Laboratories, which is the assignee of the Seitz et al. application. Owen was the owner of Owen Laboratories, which, in July of 1966, became a division of Berkleonics Corporation. At the time his testimony was taken, Owen was an employee of the Burroughs Corporation.

Owen testified about the work he performed on behalf of Seitz et al. and the report he wrote concerning that work. Owen stated that his instructions on what he was supposed to build and how he was to build it were received from Bowen. The report, dated February 9, 1967, was written by Owen and covered his activities prior to that date, particularly “the fall of 1966 and the winter of ’66 — ’67.” The report also included a photograph of the device, built by Owen himself, which is discussed in the report. Owen described the clot timing device by referring to that photograph, and, as described by him, the device shown in that [1361]*1361photograph is within the scope of count 3. Owen further testified that, although Bowen suggested using a steel ball as the “freely movable ferromagnetic member disposed in the container”, he used a flat steel disc with holes in it as the “ferromagnetic member.”

With regard to the testing of the device, Owen testified as follows:

Q52. Now, in your work on this device did you find that the results were satisfactory or unsatisfactory, and did or did not the mechanism do the job which you intended it to do? A. Extremely satisfactory. It worked out so well that we, of course, having done the development, were extremely pleased, and Hyland, as represented by John Bowen, were elated at the possibilities for an instrument which opened up with this initial success.
Q53. Under paragraph C on page two under the title “Clot Detection” can you explain that a little bit, as to what that mechanism was, particularly with reference to the paragraph, if it is there shown? A. Well, when we first started working with the clot detector our main interest was in just seeing if the clot would stop the movement of a metal piece, and of course, we could tell that just by watching it. But, of course, for a finished instrument you don’t want to have to watch one, or perhaps a line of these things operating, and so our purpose, eventual purpose, had to be to come up with a means of electrically, preferably electrically, perhaps optically, detecting the stoppage of motion, and preferably in such a way that it would print out on the little printout that Hyland intended to incorporate into its systems. So we felt our obvious path here, being electrical people, was to work with electrical signals, and so upon consideration of the problem I thought it would most easily be done by wrapping a test coil, auxiliary coil, around one leg of the electromagnets, and see what sort of system — what sort of signal was induced in the test coil when the motion stopped.
My first test then consisted of connecting this test coil to an ordinary laboratory oscilloscope; and sure enough! I could see on the screen of the oscilloscope that a quite sizable voltage was induced when clotting took place.
Q54. Now, that’s the coil that you previously designated by reference numeral on page four? A. Numeral 18.
Q55. Yes, that’s the coil? A. The coil, number 18.
Q56. Now, did you then go past the oscilloscope stage? A. Oh, yes. An oscilloscope, of course, is an engineer’s tool and not a clinical technician’s apparatus, so I took a meter—
Q57. Which is shown in the photograph? A. Which is number 20 in the photograph.
Q58. Please proceed. A. Put it in a cardboard box, because of economy and need for speed. As I remember, I made a simple semi-conductor rectifier bridge to convert the a.c. which is induced in the coil, into d.c., which would move the meter, connected it up and found that sure enough! When the blood clot formed it stopped the disc, induced the voltage in the test coil, which then caused the meter pointer to kick over quite decidedly, and in such a manner that a nonelectrical person could easily tell that clotting took place.
Q59. In paragraph D, the title of which is “Effect of Agitation”, I believe you previously mentioned something about that, but please explain, if you will, just what you did there? A. Well, of course, the proof of the pudding is the eating, and what you are doing in the electrical lab is not good enough to convince clinical people, so we took the basic elements of our system over to the Hyland Glendale plant. In working with one of their technicians one afternoon we made up quite a lot of clotting samples, measured their clotting time, using conventional methods and agitation and a stopwatch, and got an average of—
[1362]*1362Q60. These were blood samples? A. Yes, plasma, blood plasma samples.
Q61. Please proceed. A. Got an average of, I say here in the report, of some 11.8 seconds. Then from the same lot of plasma we conducted a series of tests, using the machine, and came out with some 12 seconds, or so, as the clotting time. We considered this to be a satisfactory indication of success, because the difference was, in our opinion, quite insignificant.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Kenexa Brassring, Inc. v. Taleo Corp.
751 F. Supp. 2d 735 (D. Delaware, 2010)
Solvay, S.A. v. Honeywell Specialty Materials LLC
591 F. Supp. 2d 729 (D. Delaware, 2008)
Izumi Products Co. v. Koninklijke Philips Electronics N.V.
315 F. Supp. 2d 589 (D. Delaware, 2004)
Loral Fairchild Corp. v. Victor Co. of Japan, Ltd.
931 F. Supp. 1014 (E.D. New York, 1996)
F. Brantley Scott and John H. Burton v. Roy P. Finney
34 F.3d 1058 (Federal Circuit, 1994)
Barmag Barmer Maschinenfa-Brik AG v. Murata Machinery, Ltd.
559 F. Supp. 491 (W.D. North Carolina, 1983)
Wiesner v. Weigert
666 F.2d 582 (Customs and Patent Appeals, 1981)
Piher, S. A. v. Cts Corporation
664 F.2d 122 (Seventh Circuit, 1981)
Standard Oil Company v. Montedison
494 F. Supp. 370 (D. Delaware, 1980)
Randolph v. Shoberg
590 F.2d 923 (Customs and Patent Appeals, 1979)
Peeler v. Miller
535 F.2d 647 (Customs and Patent Appeals, 1976)
Cochran v. Kresock
530 F.2d 385 (Customs and Patent Appeals, 1976)

Cite This Page — Counsel Stack

Bluebook (online)
517 F.2d 1359, 186 U.S.P.Q. (BNA) 209, Counsel Stack Legal Research, https://law.counselstack.com/opinion/steinberg-v-seitz-ccpa-1975.